Dianthus Therapeutics, Inc. (DNTH)
79.82
+0.49
(+0.62%)
USD |
NASDAQ |
Oct 27, 12:23
Dianthus Therapeutics Price to Book Value : 3.732 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 3.709 |
| October 23, 2026 | 3.590 |
| October 22, 2026 | 3.672 |
| October 21, 2026 | 3.652 |
| October 20, 2026 | 3.682 |
| October 19, 2026 | 3.485 |
| October 16, 2026 | 3.371 |
| October 15, 2026 | 3.485 |
| October 14, 2026 | 3.495 |
| October 13, 2026 | 3.627 |
| October 12, 2026 | 3.814 |
| October 09, 2026 | 3.851 |
| October 08, 2026 | 3.854 |
| October 07, 2026 | 3.969 |
| October 06, 2026 | 3.993 |
| October 05, 2026 | 4.116 |
| October 02, 2026 | 4.124 |
| October 01, 2026 | 4.129 |
| September 30, 2026 | 4.117 |
| September 29, 2026 | 4.075 |
| September 28, 2026 | 4.106 |
| September 25, 2026 | 4.140 |
| September 24, 2026 | 4.241 |
| September 23, 2026 | 4.369 |
| September 22, 2026 | 4.598 |
| Date | Value |
|---|---|
| September 21, 2026 | 4.510 |
| September 18, 2026 | 4.526 |
| September 17, 2026 | 4.728 |
| September 16, 2026 | 4.792 |
| September 15, 2026 | 4.898 |
| September 14, 2026 | 5.035 |
| September 11, 2026 | 4.965 |
| September 10, 2026 | 4.829 |
| September 09, 2026 | 5.005 |
| September 08, 2026 | 5.102 |
| September 04, 2026 | 5.054 |
| September 03, 2026 | 5.043 |
| September 02, 2026 | 4.967 |
| September 01, 2026 | 4.985 |
| August 31, 2026 | 4.938 |
| August 28, 2026 | 4.949 |
| August 27, 2026 | 5.215 |
| August 26, 2026 | 5.179 |
| August 25, 2026 | 5.242 |
| August 24, 2026 | 5.146 |
| August 21, 2026 | 5.194 |
| August 20, 2026 | 5.120 |
| August 19, 2026 | 5.316 |
| August 18, 2026 | 5.402 |
| August 17, 2026 | 5.370 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Verastem, Inc. | 18.14 |
| ACADIA Pharmaceuticals, Inc. | 2.666 |
| Alnylam Pharmaceuticals, Inc. | 22.27 |
| Anika Therapeutics, Inc. | 2.083 |
| Savara, Inc. | 6.791 |
Price to Book Value Related Metrics
| PS Ratio | 1958.06 |
| PEG Ratio | -0.6973 |
| Price | 79.82 |
| Earnings Yield | -5.20% |
| Market Cap | 4.374B |
| PEGY Ratio | -0.6973 |